Date | Time | Source | Headline | Symbol | Company |
05/07/2024 | 12:51PM | iHub Newswire | FeaturedCannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa | | |
05/07/2024 | 5:45AM | PR Newswire (US) | The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders | NASDAQ:AVXL | Anavex Life Sciences Corporation |
05/06/2024 | 6:03AM | Edgar (US Regulatory) | Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material | NASDAQ:AVXL | Anavex Life Sciences Corporation |
05/03/2024 | 5:45AM | PR Newswire (US) | Anavex Life Sciences Corporation Sued for Securities Law Violations - Contact The Gross Law Firm Before May 13, 2024 to Discuss Your Rights - AVXL | NASDAQ:AVXL | Anavex Life Sciences Corporation |
05/02/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences to Announce Fiscal 2024 Second Quarter Financial Results on Thursday, May 9th, 2024 | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/26/2024 | 5:45AM | PR Newswire (US) | May 13, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against AVXL | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/19/2024 | 5:45AM | PR Newswire (US) | Contact The Gross Law Firm by May 13, 2024 Deadline to Join Class Action Against Anavex Life Sciences Corporation(AVXL) | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/16/2024 | 5:45AM | PR Newswire (US) | The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of May 13, 2024 in Anavex Life Sciences Lawsuit - AVXL | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/12/2024 | 5:45AM | PR Newswire (US) | Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/11/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences to Present at the Noble Capital Markets Virtual Healthcare Equity Conference | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/09/2024 | 5:45AM | PR Newswire (US) | Class Action Filed Against Anavex Life Sciences Corporation (AVXL) - May 13, 2024 Deadline to Join - Contact The Gross Law Firm | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/05/2024 | 5:45AM | PR Newswire (US) | Anavex Life Sciences Corporation Class Action: The Gross Law Firm Reminds Anavex Life Sciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of May 13, 2024 - AVXL | NASDAQ:AVXL | Anavex Life Sciences Corporation |
04/02/2024 | 5:45AM | PR Newswire (US) | Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL | NASDAQ:AVXL | Anavex Life Sciences Corporation |
03/29/2024 | 5:45AM | PR Newswire (US) | Lost Money on Anavex Life Sciences Corporation(AVXL)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm | NASDAQ:AVXL | Anavex Life Sciences Corporation |
03/26/2024 | 5:45AM | PR Newswire (US) | Investors who lost money on Anavex Life Sciences Corporation(AVXL) should contact The Gross Law Firm about pending Class Action - AVXL | NASDAQ:AVXL | Anavex Life Sciences Corporation |
03/25/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences to Present at the 23rd Annual Needham Virtual Healthcare Conference | NASDAQ:AVXL | Anavex Life Sciences Corporation |
03/22/2024 | 5:45AM | PR Newswire (US) | AVXL LAWSUIT ALERT: The Gross Law Firm Notifies Anavex Life Sciences Corporation Investors of a Class Action Lawsuit and Upcoming Deadline | NASDAQ:AVXL | Anavex Life Sciences Corporation |
03/18/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences Initiates Placebo-Controlled U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/26/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences to Present at the 44th Annual TD Cowen Health Care Conference | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/23/2024 | 6:05AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/23/2024 | 6:04AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/23/2024 | 6:04AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/23/2024 | 6:03AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/23/2024 | 6:03AM | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of securities | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/07/2024 | 4:31PM | Edgar (US Regulatory) | Form 10-Q - Quarterly report [Sections 13 or 15(d)] | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/07/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences Reports Fiscal 2024 First Quarter Financial Results and Provides Business Update | NASDAQ:AVXL | Anavex Life Sciences Corporation |
02/01/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024 | NASDAQ:AVXL | Anavex Life Sciences Corporation |
01/25/2024 | 5:01PM | Edgar (US Regulatory) | Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] | NASDAQ:AVXL | Anavex Life Sciences Corporation |
01/24/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences Reports Publication of ANAVEX®3-71 in Clinical Journal Confirming Pharmacokinetic Dose Proportionality of ANAVEX®3-71 in Humans | NASDAQ:AVXL | Anavex Life Sciences Corporation |
01/16/2024 | 7:30AM | GlobeNewswire Inc. | Anavex Life Sciences Announces U.S. Phase 2 Clinical Trial of ANAVEX®3-71 in Schizophrenia | NASDAQ:AVXL | Anavex Life Sciences Corporation |